Literature DB >> 12791890

Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.

Lynn L Horvath1, Duane R Hospenthal, Clinton K Murray, David P Dooley.   

Abstract

CHROMagar Candida is a selective and differential chromogenic medium that has been shown to be useful for identification of Candida albicans, Candida krusei, Candida tropicalis, and perhaps Candida glabrata. Colony morphology and color have been well defined when CHROMagar Candida has been used to isolate yeast directly from clinical specimens, including stool, urine, respiratory, vaginal, oropharyngeal, and esophageal sources. Direct isolation of yeast on CHROMagar Candida from blood cultures has not been evaluated. We evaluated whether the color and colony characteristics produced by Candida spp. on CHROMagar Candida were altered when yeasts were isolated directly from blood cultures. Fifty clinical isolates of Candida were inoculated into aerobic and anaerobic blood culture bottles and incubated at 35 degrees C in an automated blood culture system. When growth was detected, an aliquot was removed and plated onto CHROMagar Candida. As a control, CHROMagar Candida plates were inoculated with the same isolate of yeast grown on Sabouraud dextrose agar simultaneously. No significant difference was detected in color or colony morphology between the blood and control isolates in any of the tested organisms. All C. albicans (n = 12), C. tropicalis (n = 12), C. glabrata (n = 9), and C. krusei (n = 5) isolates exhibited the expected species-specific colony characteristics and color, whether isolated directly from blood or from control cultures. CHROMagar Candida can be reliably used for direct isolation of yeast from blood cultures. Direct isolation could allow mycology laboratories to more rapidly identify Candida spp., enable clinicians to more quickly make antifungal agent selections, and potentially decrease patient morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791890      PMCID: PMC156566          DOI: 10.1128/JCM.41.6.2629-2632.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Evaluation of a reformulated CHROMagar Candida.

Authors:  M A Jabra-Rizk; T M Brenner; M Romagnoli; A A Baqui; W G Merz; W A Falkler; T F Meiller
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory.

Authors:  A P Koehler; K C Chu; E T Houang; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

3.  Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

Authors:  J L Lopez-Ribot; R K McAtee; S Perea; W R Kirkpatrick; M G Rinaldi; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  A comparison of methods for yeast identification including CHROMagar Candida, Vitek system YBC and a traditional biochemical method.

Authors:  L U Huang; C H Chen; C F Chou; J J Lu; W M Chi; W H Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-10

5.  Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.

Authors:  S W Redding; R C Zellars; W R Kirkpatrick; R K McAtee; M A Caceres; A W Fothergill; J L Lopez-Ribot; C W Bailey; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium.

Authors:  Duane R Hospenthal; Clinton K Murray; Miriam L Beckius; Judith A Green; David P Dooley
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

8.  An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory.

Authors:  S Ainscough; C C Kibbler
Journal:  J Med Microbiol       Date:  1998-07       Impact factor: 2.472

9.  Use of CHROMagar Candida medium for isolation of yeasts from dental samples.

Authors:  D Beighton; R Ludford; D T Clark; S R Brailsford; C L Pankhurst; G F Tinsley; J Fiske; D Lewis; B Daly; N Khalifa
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

10.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more
  15 in total

1.  Accuracy of species-level identification of yeast isolates from blood cultures from 10 university hospitals in South Korea by use of the matrix-assisted laser desorption ionization-time of flight mass spectrometry-based Vitek MS system.

Authors:  Eun Jeong Won; Jong Hee Shin; Kyungwon Lee; Mi-Na Kim; Hye Soo Lee; Yeon-Joon Park; Min Young Joo; Soo Hyun Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

2.  CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.

Authors:  Grace L Tan; Ellena M Peterson
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of mangalore.

Authors:  Yashavanth R; Shiju M P; Bhaskar U A; Ronald R; Anita K B
Journal:  J Clin Diagn Res       Date:  2013-11-10

4.  First case report of bloodstream infection due to a Candida species closely related to the novel species Candida pseudorugosa.

Authors:  Constanza Giselle Taverna; Susana Córdoba; Guillermina Isla; Norma Fernández; Susana García; Mariana Mazza; Omar Alejandro Murisengo; Walter Vivot; Wanda Szusz; Graciela Davel; Iris Nora Tiraboschi; María Eugenia Bosco-Borgeat
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

5.  Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species.

Authors:  Elena Eraso; María D Moragues; María Villar-Vidal; Ismail H Sahand; Nagore González-Gómez; José Pontón; Guillermo Quindós
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared with Other Commercially Available Formulations.

Authors:  Auke W de Jong; Chendo Dieleman; Mauricio Carbia; Ratna Mohd Tap; Ferry Hagen
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

Review 7.  Advances in Candida detection platforms for clinical and point-of-care applications.

Authors:  Mohammadali Safavieh; Chad Coarsey; Nwadiuto Esiobu; Adnan Memic; Jatin Mahesh Vyas; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Biotechnol       Date:  2016-04-19       Impact factor: 8.429

8.  Isolation and Speciation of Candida in Type II Diabetic Patients using CHROM Agar: A Microbial Study.

Authors:  Usha Sharma; Krupa Patel; Vandana Shah; Surabhi Sinha; Vishnu Pratap Singh Rathore
Journal:  J Clin Diagn Res       Date:  2017-08-01

9.  Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.

Authors:  Duane R Hospenthal; Miriam L Beckius; Karon L Floyd; Lynn L Horvath; Clinton K Murray
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-01-03       Impact factor: 3.944

10.  Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials.

Authors:  M V Pravin Charles; Arunava Kali; Noyal Mariya Joseph
Journal:  Pharmacognosy Res       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.